Agreement offers exclusive rights to commercialize six products in key areas of anti-infectives and oncology.Products from Adalvo slated for near- to mid-term launches, with four out of six anticipated to be first-to-marketSandoz continues to expand patient access to much-needed medications,…
Source: www.novartis.com – Read more
Sandoz to exclusively commercialize six products in the US, reinforcing global leadership position in off-patent medicines
Must Read
The Top 10 endpoint security challenges and how to overcome them
Join top executives in San Francisco on July 11-12, to hear how leaders are integrating and optimizing AI investments for success. Learn More
One of...
